Replicate the success of CAR-T to the non-oncology field, bringing cell engineering to the new high

Solutions

MSC

Our platforms

Replicate the success of CAR-T to the non-oncology field, bringing cell engineering to the new high

Addressing problems of current cell therapies

We aim to bring new hopes to patients with our cutting-edge
platform technologies and creative approaches

Addressing problems of current cell therapies

We aim to bring new hopes to patients with our cutting-edge platform technologies and creative approaches

MSC: the foundation of our cell therapy products

Mesenchymal stromal cells exert multiple therapeutic effects through
cytokine and growth factor secretions. They are safe, easy to expand,
and can be used as allogeneic therapies.

MSC: the foundation of our cell therapy products

Mesenchymal stromal cells exert multiple therapeutic effects through cytokine and growth factor secretions. They are safe, easy to expand, and can be used as allogeneic therapies.

Our robust, GMP-compliant manufacturing process

Four key platforms to create clinical-grade supercarrier MSC

Our robust, GMP-compliant manufacturing process

Four key platforms to create clinical-grade supercarrier MSC

At Taiwan Bio, we are an expert in developing engineered cells to treat non-oncology diseases. Our innovative vector platform allows us to engineer various cell types.

At Taiwan Bio, we are an expert in developing engineered cells to treat non-oncology diseases. Our innovative vector platform allows us to engineer various cell types.